GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study

NEXT STORY
RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
PREV STORY
Zai Lab Announces Positive Topline Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) as First-Line Monotherapy Maintenance Treatment in Chinese Women with Platinum-Responsive Advanced Ovarian Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

World Champion Swimmer and Twelve-Time Medalist Dara Torres Partners with Vericel for the ‘It’s Your Move’ Campaign

CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in ...

author_avatar
NASDAQ Market News

Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group

author_avatar
NASDAQ Market News

Publications Validate Clinical Safety and Efficacy of Shockwave Intravascular Lithotripsy

author_avatar
NASDAQ Market News